| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/20/2001 | CA2401252A1 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | CA2373414A1 A novel factor-h related protein 5 and antobodies thereto |
| 09/20/2001 | CA2373110A1 Production of chimeric capsid vectors |
| 09/19/2001 | EP1133564A1 Zace1: a human metalloenzyme |
| 09/19/2001 | EP1133563A2 Methods and molecules relating to cd39-like polypeptides |
| 09/19/2001 | EP1133558A1 Compositions and methods for increasing bone mineralization |
| 09/19/2001 | EP1133520A2 Compositions and methods using lactadherin or variants thereof |
| 09/19/2001 | EP1133519A2 Functional antagonists of hedgehog activity |
| 09/19/2001 | EP0591369B1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 09/18/2001 | US6291654 Obtaining protein sample from bacteria, applying to solid support of methylamine treated complement protein c3, washing solid support, and removing c3 binding protein from solid support using alcohol solution |
| 09/18/2001 | US6291650 Methods for producing members of specific binding pairs |
| 09/18/2001 | US6291646 A receptor polypeptide having a ligand-binding domain joined to an immunoglobulin constant region; therapy for atherosclerosis, autocrine tumors, fibroplasia and keloid formation |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291212 Nucleotide sequences coding polypeptide for the detection and purification of human platelet derived growth factor or isoforms |
| 09/18/2001 | US6291208 Exprsssion vector; for use as diagnostic tools and generating vaccines |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290962 Urease-based vaccine and treatment for helicobacter infection |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/13/2001 | WO2001066785A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | WO2001066762A1 Human extracellular signal regulated kinases |
| 09/13/2001 | WO2001066732A1 Human abc transporter expressed in liver, atil |
| 09/13/2001 | WO2001066563A2 T1r taste receptors and genes encoding same |
| 09/13/2001 | CA2402412A1 Human extracellular signal regulated kinases |
| 09/13/2001 | CA2402214A1 T1r taste receptors and genes encoding same |
| 09/13/2001 | CA2402211A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | CA2401964A1 New abc transporter atil |
| 09/12/2001 | EP1131433A1 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 09/12/2001 | EP1131411A2 Suppression of xenotransplant rejection |
| 09/12/2001 | EP1131352A2 Rantes-derived peptides with anti-hiv activity |
| 09/12/2001 | EP1131351A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP0621898B1 Chimeric immunogens |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |
| 09/11/2001 | US6288032 Polypeptides for osteoporosis and other bone disorder treatment |
| 09/11/2001 | US6287817 Administering fusion protein of single chain fv molecule against transcytotic receptor linked to therapeutic protein; delivers protein to epithelial cell; treatment of cystic fibrosis |
| 09/11/2001 | US6287565 Modified HGP-30 heteroconjugates, compositions and methods of use |
| 09/11/2001 | US6287562 Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugates |
| 09/07/2001 | WO2001065262A2 Reagents and methods useful for detecting diseases of the breast |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064922A2 Heterologous expression of neisserial proteins |
| 09/07/2001 | WO2001064920A2 Hybrid expression of neisserial proteins |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064877A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064876A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064843A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001012812A3 Baff receptor (bcma), an immunoregulatory agent |
| 09/07/2001 | CA2744921A1 Hybrid expression of neisserial proteins |
| 09/07/2001 | CA2689666A1 Heterologous expression of neisserial proteins |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401544A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 09/07/2001 | CA2401175A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | CA2400679A1 Human schizophrenia gene |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/05/2001 | EP1129201A1 Lysozyme fusion proteins in infections |
| 09/05/2001 | EP0513090B1 Hepatitis a vaccines |
| 09/05/2001 | CN1311688A Synthetic somatostatin immunogen for growth promotion in farm animals |
| 09/05/2001 | CN1311332A Producing erythrocyte irritable factor/granulocyte colony irritable factor fusion protein by genetic engineering method |
| 09/04/2001 | US6284870 Gamma retinoic acid receptor |
| 09/04/2001 | US6284740 Osteoprotegerin |
| 09/04/2001 | US6284728 Osteoprotegerin |
| 09/04/2001 | US6284485 Nucleic acids encoding osteoprotegerin |
| 09/04/2001 | US6284240 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 08/30/2001 | WO2001063295A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062919A1 Modified fluorescent proteins |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001012806A3 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 08/30/2001 | WO2001009187A3 Human monoclonal antibodies to her2/neu |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400642A1 Modified fluorescent proteins |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/29/2001 | EP1127140A2 Fk506-based regulation of biological events |
| 08/29/2001 | EP1127134A1 Rotavirus subunit vaccine |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127116A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP0828758B1 Chimeric fatty body-pro-grf analogs with increased biological potency |
| 08/29/2001 | CN1310763A New peptide fragments for protein purification |
| 08/29/2001 | CN1310759A Therapeutic and diagnostic domain 1 & beta 2GP1 polypeptides and methods of using same |
| 08/29/2001 | CN1310628A Method of raising animals for meat production |
| 08/29/2001 | CN1310626A Hybrid polypeptides with enhanced pharmacokinetic properties |
| 08/28/2001 | US6280974 Nucleotide sequence coding viral protein; for use as diagnostic tool in detection of viral diseases |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060970A2 Zinc finger domains and methods of identifying same |
| 08/23/2001 | WO2001060866A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001012215A3 Protective antigen of Epstein barr virus |